BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3436049)

  • 1. Relationship of branched-chain alpha-keto-acids and lipids in sera of hypertriglyceridemic subjects.
    Penttilä IM; Herranen J; Lampainen E; Voutilainen E
    Clin Chim Acta; 1987 Dec; 170(2-3):143-9. PubMed ID: 3436049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and metabolic interrelationships among branched-chain keto and amino acids in humans.
    Schauder P
    J Lab Clin Med; 1985 Dec; 106(6):701-7. PubMed ID: 4067381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral metabolism of branched-chain keto acids in patients with chronic renal failure.
    Garibotto G; Paoletti E; Fiorini F; Russo R; Robaudo C; Deferrari G; Tizianello A
    Miner Electrolyte Metab; 1993; 19(1):25-31. PubMed ID: 8345831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-keto and alpha-hydroxy branched-chain acid interrelationships in normal humans.
    Hoffer LJ; Taveroff A; Robitaille L; Mamer OA; Reimer ML
    J Nutr; 1993 Sep; 123(9):1513-21. PubMed ID: 8360777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood levels of branched-chain alpha-keto acids in uremia: effect of an oral glucose tolerance test.
    Schauder P; Matthaei D; Henning HV; Scheler F; Langenbeck U
    Klin Wochenschr; 1981 Aug; 59(15):845-9. PubMed ID: 7021997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
    Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
    Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J; Goy-Loeper J; Rouffy J
    Clin Chim Acta; 1979 Oct; 98(1-2):19-26. PubMed ID: 227624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.
    Harris WS; Dujovne CA; Zucker M; Johnson B
    Ann Intern Med; 1988 Sep; 109(6):465-70. PubMed ID: 3166357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemia and familial combined hyperlipidemia.
    Ohta T; Kiwaki K; Endo F; Umehashi H; Matsuda I
    Pediatr Int; 2002 Dec; 44(6):602-7. PubMed ID: 12421255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum branched chain amino and keto acid response to fasting in humans.
    Schauder P; Herbertz L; Langenbeck U
    Metabolism; 1985 Jan; 34(1):58-61. PubMed ID: 3965862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
    Singer P; Hüve J
    Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for valine intolerance in patients with cirrhosis.
    Schauder P; Schröder K; Herbertz L; Langer K; Langenbeck U
    Hepatology; 1984; 4(4):667-70. PubMed ID: 6745855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of orally administered branched-chain alpha-keto acids.
    Dalton RN; Chantler C
    Kidney Int Suppl; 1983 Nov; 15():S11-5. PubMed ID: 6368946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
    Sale JK; Johnstone JH
    Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.